◆英語タイトル:Centogene AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11222
◆発行会社(調査会社):
GlobalData
◆発行日:2018年11月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Centogene AG (Centogene) is a biotechnology and genetic diagnostic company which offers genetic testing for rare hereditary disorders. The company provides diagnostic services including whole genome sequencing, whole exome sequencing, clinical exome sequencing, NGS panel genomic, carrier screening, and non-invasive prenatal testing. Centogene provides targeted services such as hereditary mutations for oncogenetics, somatic mutations for oncogenetics, male and female infertility testing panel, genetic testing of newborns and mitochondrial disease testing. The company’s digital services include CentoCloud bioinformatics solution, a service designed for human genetic laboratories to support next generation sequencing diagnostics; and CentoMD mutation database. It has operational presence in Germany, Austria, India and the UAE. Centogene is headquartered in Rostock, Germany.
Centogene AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Centogene AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Centogene AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Centogene AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Centogene AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Centogene AG, Medical Devices Deals, 2012 to YTD 2018 9
Centogene AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Centogene AG, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Centogene Raises USD28 Million in Series A Financing 11
Partnerships 12
Centogene and Denali Therapeutics Enter into Agreement 12
Centogene and Evotec Enter into Co-Development Agreement 13
Centogene Enters into Agreement with Aldeyra Therapeutics 14
Centogene Enters into Agreement with Orphazyme 15
Centogene Partners with Filgen 16
Centogene Partners with Mikrogen 17
Asset Transactions 18
LifeLabs Medical Labs Acquires Genteic Testing Business Of Centogene 18
Centogene AG – Key Competitors 19
Centogene AG – Key Employees 20
Centogene AG – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Corporate Communications 22
May 04, 2018: CENTOGENE Appoints Berndt Modig as New Supervisory Board Member 22
Apr 10, 2018: CENTOGENE Expands Executive Team, Appoints Dr. Dirk Ehlers Chief Operating Officer 23
Legal and Regulatory 24
Oct 04, 2017: CENTOGENE received the Continuation of Accreditation Notice for the CAP 15189 Accreditation Program 24
Jan 27, 2017: CENTOGENE successfully renewed accreditation from College of American Pathologists 25
Other Significant Developments 26
Feb 28, 2018: CENTOGENE’s “50+new genes” initiative – “Un-Rare” rare diseases 26
Jan 31, 2018: CENTOGENE Surpasses One Billion Identified Alleles within World’s Largest Patient Database of Rare Genetic Disorders 27
May 05, 2017: Another milestone is reached for the new headquarter in Rostock 28
Feb 02, 2017: Centogene: Our new headquarter is growing rapidly 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30
List of Tables
Centogene AG, Pharmaceuticals & Healthcare, Key Facts 2
Centogene AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Centogene AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Centogene AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Centogene AG, Deals By Therapy Area, 2012 to YTD 2018 8
Centogene AG, Medical Devices Deals, 2012 to YTD 2018 9
Centogene AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Centogene Raises USD28 Million in Series A Financing 11
Centogene and Denali Therapeutics Enter into Agreement 12
Centogene and Evotec Enter into Co-Development Agreement 13
Centogene Enters into Agreement with Aldeyra Therapeutics 14
Centogene Enters into Agreement with Orphazyme 15
Centogene Partners with Filgen 16
Centogene Partners with Mikrogen 17
LifeLabs Medical Labs Acquires Genteic Testing Business Of Centogene 18
Centogene AG, Key Competitors 19
Centogene AG, Key Employees 20
Centogene AG, Subsidiaries 21
List of Figures
Centogene AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Centogene AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Centogene AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Centogene AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Centogene AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Centogene AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Centogene AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Centogene AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Centogene AG, Medical Devices Deals, 2012 to YTD 2018 9